Tampa General Hospital Adopts MeMed BV to Enhance Sepsis Care
Event summary
- Tampa General Hospital is the first academic health system in the Southeast to adopt MeMed BV, a diagnostic test that distinguishes bacterial from viral infections in 15 minutes.
- The test was integrated into the hospital's existing electronic health record (EHR)-based ED sepsis alert workflow.
- A study of 893 adult emergency department patients showed that MeMed BV reclassified 26% more patients as unlikely to have sepsis, reduced cefepime exposure by 33%, and decreased hospitalizations by 13%.
- The research was presented at the Society for Academic Emergency Medicine (SAEM) Annual Meeting in May 2026 and the Association for Diagnostics & Laboratory Medicine (ADLM) meeting in July 2026.
The big picture
Tampa General Hospital's adoption of MeMed BV aligns with broader trends in precision medicine and the push for more targeted diagnostic tools. The integration of this technology into existing workflows highlights the growing importance of real-time data in clinical decision-making. This move could set a precedent for other health systems looking to enhance their sepsis care protocols through innovative diagnostic solutions.
What we're watching
- Clinical Impact
- How the integration of MeMed BV will affect sepsis care outcomes and antibiotic stewardship efforts.
- Operational Efficiency
- Whether the reduction in hospitalizations and antibiotic use will lead to significant cost savings.
- Technology Adoption
- The pace at which other academic health systems will adopt similar host-response technologies.
Related topics